<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A cerebral injury was induced by the bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and recirculation in spontaneously hypertensive rats (SHRs) </plain></SENT>
<SENT sid="1" pm="."><plain>Employing this <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-recirculation rat model, the effects of beraprost <z:chebi fb="199" ids="26708">sodium</z:chebi> (beraprost) on (1) <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="39" ids="44785">peroxide</z:chebi> formation, (2) the increase in the brain water content and (3) neurological signs were examined </plain></SENT>
<SENT sid="2" pm="."><plain>In a dosage of 25 micrograms kg-1 or higher, beraprost, administered orally, significantly inhibited the formation of <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="39" ids="44785">peroxides</z:chebi> in the brain and serum induced by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and subsequent recirculation in a dose-dependent manner </plain></SENT>
<SENT sid="3" pm="."><plain>Beraprost also alleviated <z:hpo ids='HP_0000508'>ptosis</z:hpo> and markedly inhibited abnormal running behaviour caused by the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and subsequent recirculation </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, although administration of beraprost did not cause marked inhibition of the increase in the brain water content (used as an index of cerebral <z:hpo ids='HP_0000969'>oedema</z:hpo>) during the first 3 h after recirculation, it restored the <z:mpath ids='MPATH_458'>normal</z:mpath> brain water content within 24 h after recirculation </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, this effect was observed evidently later than the effect of inhibition of <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="39" ids="44785">peroxide</z:chebi> formation </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, administration of beraprost resulted in improvement in the symptoms accompanying the ischemic treatment </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that beraprost is potentially useful for or treatment of the pathological state accompanying <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>